NeuroSense Therapeutics Ltd. (NRSNW) Net income 2021–2025
NeuroSense Therapeutics Ltd. (NRSNW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.1MFY2025 · since FY2021: -$3.2M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | -9.0% |
| FY2024 | -$10.2M | -1.0% |
| FY2023 | -$10.1M | +3.7% |
| FY2022 | -$10.5M | -225.8% |
| FY2021 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice